Prediabetes Diagnosis and Management
Diagnose prediabetes using any of three criteria: A1C 5.7–6.4% (39–47 mmol/mol), fasting plasma glucose 100–125 mg/dL, or 2-hour plasma glucose 140–199 mg/dL during a 75-g oral glucose tolerance test (OGTT), and immediately initiate intensive lifestyle modification as first-line therapy for all patients. 1
Diagnostic Criteria
Prediabetes is defined by meeting any one of the following three laboratory thresholds 1:
- A1C: 5.7–6.4% (39–47 mmol/mol)
- Fasting plasma glucose: 100–125 mg/dL (5.6–6.9 mmol/L)
- 2-hour plasma glucose during 75-g OGTT: 140–199 mg/dL (7.8–11.0 mmol/L)
All three tests are equally appropriate for screening 1. When using OGTT, ensure adequate carbohydrate intake of at least 150 g/day for 3 days prior to testing 1.
Who to Screen
Screen all adults starting at age 35 years, regardless of other risk factors 1.
Screen earlier (any age) in adults with overweight/obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian ancestry) who have one or more of these risk factors 1:
- First-degree relative with diabetes
- High-risk race/ethnicity (African American, Latino, Native American, Asian American)
- History of cardiovascular disease
- Hypertension (≥130/80 mmHg or on therapy)
- HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL
- Polycystic ovary syndrome
- Physical inactivity
- Insulin resistance conditions (severe obesity, acanthosis nigricans, metabolic dysfunction-associated steatotic liver disease)
Repeat screening intervals 1:
- Annually if prediabetes is diagnosed
- Every 1–3 years if history of gestational diabetes
- Every 3 years minimum if normal results (sooner with weight gain or new risk factors)
Management Strategy
First-Line: Intensive Lifestyle Modification (All Patients)
Intensive lifestyle modification reduces diabetes incidence by 6.2 cases per 100 person-years over 3 years—the most effective intervention available 2. This consists of 3, 2:
- Weight loss goal: ≥5% of body weight
- Physical activity: ≥150 minutes per week
- Calorie restriction (especially refined carbohydrates and saturated fats)
- Self-monitoring and motivational support
Pharmacotherapy Indications
Add metformin for patients at particularly high risk of progression to diabetes 3, 2:
- BMI ≥35 kg/m², OR
- Fasting plasma glucose 110–125 mg/dL (6.1–6.9 mmol/L), OR
- 2-hour postchallenge glucose 173–199 mg/dL (9.6–11.0 mmol/L), OR
- A1C ≥6.0% (≥42 mmol/mol), OR
- History of gestational diabetes, OR
- Age <60 years with above criteria
Metformin reduces diabetes incidence by 3.2 cases per 100 person-years over 3 years 2. It is most effective in women with prior gestational diabetes and younger individuals with higher BMI and glucose levels 2.
Risk Stratification for Intensity of Intervention
The evidence clearly delineates risk levels. In the Diabetes Prevention Program, patients with the high-risk features listed above had crude diabetes incidence of 14–22 cases per 100 person-years, compared to 11 cases per 100 person-years in the general prediabetes population 3. This 27–100% increased risk justifies more intensive preventive approaches including pharmacotherapy 3.
Critical Caveats
The 2-hour OGTT value provides superior cardiovascular risk stratification. Patients with 2-hour glucose ≥140 mg/dL (impaired glucose tolerance) or 1-hour glucose ≥155 mg/dL during OGTT have significantly higher cardiovascular disease risk than those with isolated impaired fasting glucose 4. Consider OGTT rather than just fasting glucose or A1C when assessing cardiovascular risk.
Prediabetes confers excess cardiovascular mortality of 7.36 per 10,000 person-years and cardiovascular events of 8.75 per 10,000 person-years over 6.6 years 2. This is not merely a "pre-disease" state—it carries independent morbidity and mortality risk requiring aggressive management of all cardiovascular risk factors (lipids, blood pressure) 3, 4.
Annual monitoring is mandatory once prediabetes is diagnosed 1. Approximately 10% of people with prediabetes progress to diabetes each year in the US 2, making close surveillance essential for timely intervention escalation.